08.07.2014 • News • Mergers & Acquisitions (M&A) • Dede Willams • healthcare

Belgium's Omega Pharma May Sell Itself

Omega Pharma, a Belgian healthcare products distributor, is considering selling itself nearly three years after it was taken private by its founder, the news agency Bloomberg said, citing sources.

A sale of the Nazareth, Belgium-based company could earn its owners more than $4 billion, Bloomberg added.

Omega, which sells prescription-free medicines, healthcare products and over-the-counter items such as wart treatments and sun tan lotions, is believed to have hired investment bank Morgan Stanley to handle the sale, which could start as early as this month.

Founder and CEO Marc Coucke took the company private in 2011 with his $1.1 billion takeover offer for the maker of painkiller Solpadeine. 

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Top-Feature

most read

Photo
28.07.2025 • News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.